Aortech International PLC
20 August 2007
20 August 2007
AorTech International plc ('AorTech' or the 'Company')
Result of Extraordinary General Meeting
AorTech International (AIM:AOR), the biomaterials and medical device development
company, held its Extraordinary General Meeting today at which all resolutions
were passed.
- Ends -
For further information please contact:
AorTech International plc Tel: + 1 801 201 4336
Frank Maguire, Chief Executive
Evolution Securities Tel: +44 20 7071 4300
Bobbie Hilliam
Tim Worlledge
Hogarth Partnership Limited Tel: +44 20 7357 9477
Melanie Toyne-Sewell
Sarah Richardson
Notes to Editors:
About AorTech International plc
Listed on AIM in London, AorTech International plc wholly owns AorTech
Biomaterials based in Melbourne, Australia. AorTech Biomaterials was formed in
July 1997 to commercialise a range of medical grade polyurethanes for medical
implants developed by the Commonwealth Scientific and Industrial Research
Organisation (CSIRO).
AorTech's Elast-Eon technology is the product of a decade of fundamental
research into biologically stable materials. Elast-Eon materials are patented,
high silicone content, polyurethane copolymers which exhibit unparalleled
biological and mechanical performance.
AorTech is firmly focused on the development and refinement of this material for
the medical community, with the aim of providing a wide range of high
performance Elast-Eon materials in a variety of application specific
formulations and densities, for use in medical devices.
This information is provided by RNS
The company news service from the London Stock Exchange